Literature DB >> 3056740

Plasmodium falciparum: induction of resistance to mefloquine in cloned strains by continuous drug exposure in vitro.

A M Oduola1, W K Milhous, N F Weatherly, J H Bowdre, R E Desjardins.   

Abstract

A genetically homogeneous population of Plasmodium falciparum prepared by a single erythrocyte micromanipulation technique was used to produce lines of P. falciparum resistant to mefloquine hydrochloride in vitro. Parasites were maintained in a culture medium containing gradually increased concentrations of mefloquine hydrochloride (CMP-mef) starting with 2 ng/ml. One of the mefloquine-resistant culture lines (W2-mef) was obtained after 96 weeks of continuous culture in CMP-mef, the last 4 weeks in medium containing 40 ng/ml of mefloquine hydrochloride. The W2-mef was four to six times more resistant to mefloquine than was the parent clone W2. Means of multiple determinations of 50% inhibitory concentrations (IC-50) of mefloquine hydrochloride against W2-mef and clone W2 were 20.39 +/- 5.08 ng/ml and 4.50 +/- 1.94 ng/ml, respectively.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3056740     DOI: 10.1016/0014-4894(88)90082-3

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  56 in total

1.  Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum.

Authors:  A Singh; P J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

2.  Genetics of mefloquine resistance in the rodent malaria parasite Plasmodium chabaudi.

Authors:  Pedro V L Cravo; Jane M-R Carlton; Paul Hunt; Laura Bisoni; Rose Ann Padua; David Walliker
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

Review 3.  How can we identify parasite genes that underlie antimalarial drug resistance?

Authors:  Tim Anderson; Standwell Nkhoma; Andrea Ecker; David Fidock
Journal:  Pharmacogenomics       Date:  2011-01       Impact factor: 2.533

4.  Variations in frequencies of drug resistance in Plasmodium falciparum.

Authors:  P K Rathod; T McErlean; P C Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

5.  Plasmodium falciparum parasites expressing pregnancy-specific variant surface antigens adhere strongly to the choriocarcinoma cell line BeWo.

Authors:  Rikke N Haase; Rosette Megnekou; Maja Lundquist; Michael F Ofori; Lars Hviid; Trine Staalsoe
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

6.  Polymorphisms in erythrocyte binding antigens 140 and 181 affect function and binding but not receptor specificity in Plasmodium falciparum.

Authors:  Alexander G Maier; Jake Baum; Brian Smith; David J Conway; Alan F Cowman
Journal:  Infect Immun       Date:  2009-02-09       Impact factor: 3.441

7.  Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum.

Authors:  Marina Chavchich; Lucia Gerena; Jennifer Peters; Nanhua Chen; Qin Cheng; Dennis E Kyle
Journal:  Antimicrob Agents Chemother       Date:  2010-03-29       Impact factor: 5.191

8.  Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents.

Authors:  David J Johnson; David A Fidock; Mathirut Mungthin; Viswanathan Lakshmanan; Amar Bir Singh Sidhu; Patrick G Bray; Stephen A Ward
Journal:  Mol Cell       Date:  2004-09-24       Impact factor: 17.970

9.  Multidrug resistance in Leishmania donovani is conferred by amplification of a gene homologous to the mammalian mdr1 gene.

Authors:  D M Henderson; C D Sifri; M Rodgers; D F Wirth; N Hendrickson; B Ullman
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

10.  Gene copy number variation throughout the Plasmodium falciparum genome.

Authors:  Ian H Cheeseman; Natalia Gomez-Escobar; Celine K Carret; Alasdair Ivens; Lindsay B Stewart; Kevin K A Tetteh; David J Conway
Journal:  BMC Genomics       Date:  2009-08-04       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.